|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity |
ISO |
bupirimate results in increased activity of NR1I2 protein |
CTD |
PMID:16565514 PMID:21924250 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nr1i3 |
nuclear receptor subfamily 1, group I, member 3 |
increases activity |
ISO |
bupirimate results in increased activity of NR1I3 protein |
CTD |
PMID:21924250 |
|
NCBI chr13:83,632,940...83,638,193
Ensembl chr13:83,632,899...83,637,906
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions increases activity decreases expression affects localization |
ISO EXP |
cyprodinil binds to and results in increased activity of AHR protein cyprodinil results in increased activity of AHR protein cyprodinil results in decreased expression of AHR protein AHR protein affects the reaction [cyprodinil results in increased expression of CYP1A1 protein] cyprodinil affects the localization of AHR protein |
CTD |
PMID:23228475 PMID:23436777 PMID:28728110 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of AIF1 protein] [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of AIF1 protein |
CTD |
PMID:31939705 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
Anxa10 |
annexin A10 |
increases expression |
ISO |
cyprodinil results in increased expression of ANXA10 mRNA |
CTD |
PMID:32194361 |
|
NCBI chr16:27,738,712...27,805,648
Ensembl chr16:27,738,712...27,805,648
|
|
G |
App |
amyloid beta precursor protein |
affects binding multiple interactions |
ISO |
cyprodinil binds to APP protein modified form [APP gene mutant form results in increased expression of APP protein modified form] which results in increased susceptibility to cyprodinil; [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of AIF1 protein]; [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of GFAP protein]; [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of IL1B protein]; [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of IL6 protein]; APP protein modified form results in increased susceptibility to [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] |
CTD |
PMID:31939705 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Ar |
androgen receptor |
affects binding increases activity multiple interactions increases expression |
ISO |
cyprodinil binds to AR protein cyprodinil results in increased activity of AR protein cyprodinil inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; cyprodinil inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA] cyprodinil results in increased expression of AR mRNA |
CTD |
PMID:21310686 PMID:23436777 PMID:28728110 PMID:28803809 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Arg1 |
arginase 1 |
decreases expression |
ISO |
cyprodinil results in decreased expression of ARG1 mRNA |
CTD |
PMID:32194361 |
|
NCBI chr 1:20,475,878...20,488,422
Ensembl chr 1:20,475,968...20,488,422
|
|
G |
Arnt |
aryl hydrocarbon receptor nuclear translocator |
multiple interactions |
ISO |
ARNT protein affects the reaction [cyprodinil results in increased expression of CYP1A1 protein] |
CTD |
PMID:23228475 |
|
NCBI chr 2:182,997,731...183,056,584
Ensembl chr 2:182,997,736...183,056,580
|
|
G |
Bace1 |
beta-secretase 1 |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of BACE1 protein |
CTD |
PMID:31939705 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
|
|
G |
Casp3 |
caspase 3 |
increases expression multiple interactions |
ISO |
cyprodinil results in increased expression of CASP3 mRNA [pyrimethanil co-treated with cyprodinil co-treated with fludioxonil] results in increased expression of CASP3 mRNA |
CTD |
PMID:22880100 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccnd1 |
cyclin D1 |
multiple interactions increases expression |
ISO |
fulvestrant inhibits the reaction [cyprodinil results in increased expression of CCND1 protein] |
CTD |
PMID:26344002 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Ccne1 |
cyclin E1 |
increases expression multiple interactions |
ISO |
cyprodinil results in increased expression of CCNE1 protein fulvestrant inhibits the reaction [cyprodinil results in increased expression of CCNE1 protein] |
CTD |
PMID:26344002 |
|
NCBI chr 1:90,781,947...90,791,188
Ensembl chr 1:90,781,949...90,791,101
|
|
G |
Cdh1 |
cadherin 1 |
multiple interactions |
ISO |
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin co-treated with 4-hydroxy-2-nonenal] results in decreased expression of CDH1 protein; [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in decreased expression of CDH1 protein |
CTD |
PMID:34503147 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Ctsd |
cathepsin D |
increases expression multiple interactions |
ISO |
cyprodinil results in increased expression of CTSD protein fulvestrant inhibits the reaction [cyprodinil results in increased expression of CTSD protein] |
CTD |
PMID:26344002 |
|
NCBI chr 1:197,527,467...197,539,343
Ensembl chr 1:197,527,467...197,539,488
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions increases expression |
ISO |
2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [cyprodinil results in increased expression of CYP1A1 protein]; Dexamethasone inhibits the reaction [cyprodinil results in increased expression of CYP1A1 protein] cyprodinil results in increased expression of CYP1A1 mRNA; cyprodinil results in increased expression of CYP1A1 protein 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [cyprodinil results in increased expression of CYP1A1 mRNA]; 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide inhibits the reaction [cyprodinil results in increased expression of CYP1A1 protein]; AHR protein affects the reaction [cyprodinil results in increased expression of CYP1A1 protein]; ARNT protein affects the reaction [cyprodinil results in increased expression of CYP1A1 protein] |
CTD |
PMID:23228475 PMID:32194361 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp2c6 |
cytochrome P450, family 2, subfamily C, polypeptide 6 |
decreases expression |
ISO |
cyprodinil results in decreased expression of CYP2C19 protein |
CTD |
PMID:32194361 |
|
NCBI chr 1:237,938,521...237,976,238
Ensembl chr 1:237,693,094...238,057,596
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in increased expression of CYP3A4 mRNA |
CTD |
PMID:25028461 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Cyp7a1 |
cytochrome P450 family 7 subfamily A member 1 |
decreases expression |
ISO |
cyprodinil results in decreased expression of CYP7A1 mRNA; cyprodinil results in decreased expression of CYP7A1 protein |
CTD |
PMID:32194361 |
|
NCBI chr 5:19,376,979...19,386,676
Ensembl chr 5:19,376,974...19,386,688
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding increases activity |
ISO EXP |
cyprodinil binds to ESR1 protein cyprodinil results in increased activity of ESR1 protein |
CTD |
PMID:27999363 PMID:33352482 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
G6pc1 |
glucose-6-phosphatase catalytic subunit 1 |
decreases expression |
ISO |
cyprodinil results in decreased expression of G6PC1 mRNA |
CTD |
PMID:32194361 |
|
NCBI chr10:86,307,400...86,318,766
Ensembl chr10:86,257,668...86,333,804
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of GFAP protein] [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of GFAP protein |
CTD |
PMID:31939705 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
affects expression multiple interactions |
ISO |
cyprodinil affects the expression of GPX1 mRNA [pyrimethanil co-treated with cyprodinil co-treated with fludioxonil] results in increased expression of GPX1 mRNA |
CTD |
PMID:22880100 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
H2ax |
H2A.X variant histone |
increases phosphorylation multiple interactions |
ISO |
cyprodinil results in increased phosphorylation of H2AX protein [fludioxonil co-treated with cyprodinil co-treated with procymidone co-treated with iprodione co-treated with cyhalothrin] results in increased phosphorylation of H2AX protein; [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin co-treated with 4-hydroxy-2-nonenal] results in increased expression of H2AX protein; [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in increased expression of H2AX protein |
CTD |
PMID:22389207 PMID:34503147 |
|
NCBI chr 8:44,671,907...44,673,262
Ensembl chr 8:44,671,786...44,673,239
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of IL1B protein] |
CTD |
PMID:31939705 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of IL6 protein] |
CTD |
PMID:31939705 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Mapk1 |
mitogen activated protein kinase 1 |
increases phosphorylation |
ISO |
cyprodinil results in increased phosphorylation of MAPK1 protein |
CTD |
PMID:23228475 |
|
NCBI chr11:83,957,813...84,023,629
Ensembl chr11:83,957,813...84,023,616
|
|
G |
Mapk3 |
mitogen activated protein kinase 3 |
increases phosphorylation |
ISO |
cyprodinil results in increased phosphorylation of MAPK3 protein |
CTD |
PMID:23228475 |
|
NCBI chr 1:181,366,646...181,372,863
Ensembl chr 1:181,366,637...181,372,863
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions increases activity |
ISO |
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] results in increased activity of NR1I2 protein cyprodinil results in increased activity of NR1I2 protein |
CTD |
PMID:25028461 PMID:28728110 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
increases expression |
ISO |
cyprodinil results in increased expression of NRF1 mRNA |
CTD |
PMID:33352482 |
|
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression |
ISO |
cyprodinil results in increased expression of PCNA protein |
CTD |
PMID:26344002 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[cyprodinil binds to and results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of and results in decreased secretion of Prostaglandin D2 |
CTD |
PMID:26359731 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Tff1 |
trefoil factor 1 |
increases expression |
ISO |
cyprodinil results in increased expression of TFF1 mRNA |
CTD |
PMID:33352482 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|
G |
Tp53bp1 |
tumor protein p53 binding protein 1 |
multiple interactions |
ISO |
[procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin co-treated with 4-hydroxy-2-nonenal] affects the expression of TP53BP1 protein; [procymidone co-treated with iprodione co-treated with cyprodinil co-treated with fludioxonil co-treated with cyhalothrin] affects the expression of TP53BP1 protein |
CTD |
PMID:34503147 |
|
NCBI chr 3:108,166,574...108,270,229
Ensembl chr 3:108,169,980...108,269,822
|
|
|
G |
Abcg2 |
ATP binding cassette subfamily G member 2 |
increases transport multiple interactions |
ISO |
ABCG2 protein results in increased transport of ethirimol 3-(6-isobutyl-9-methoxy-1,4-dioxo-1,2,3,4,6,7,12,12a-octahydropyrazino(1',2'-1,6)pyrido(3,4-b)indol-3-yl)propionic acid tert-butyl ester inhibits the reaction [ABCG2 protein results in increased transport of ethirimol] |
CTD |
PMID:37011773 |
|
NCBI chr 4:87,676,241...87,802,757
Ensembl chr 4:87,745,319...87,802,409
|
|
|
G |
Abca1 |
ATP binding cassette subfamily A member 1 |
decreases expression |
EXP |
fenarimol results in decreased expression of ABCA1 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 5:67,678,267...67,801,162
Ensembl chr 5:67,681,297...67,801,170
|
|
G |
Acvr2b |
activin A receptor type 2B |
decreases expression |
EXP |
fenarimol results in decreased expression of SCGB2A2 mRNA |
CTD |
PMID:15590119 |
|
NCBI chr 8:119,138,901...119,178,477
Ensembl chr 8:119,138,812...119,170,458
|
|
G |
Ar |
androgen receptor |
affects binding multiple interactions |
ISO |
fenarimol binds to AR protein Dihydrotestosterone inhibits the reaction [fenarimol results in increased activity of AR protein]; fenarimol inhibits the reaction [[6-fluorotestosterone co-treated with Norgestrel] binds to and results in increased activity of AR protein]; fenarimol inhibits the reaction [Dihydrotestosterone results in increased activity of AR protein]; fenarimol inhibits the reaction [Metribolone results in increased activity of AR protein] |
CTD |
PMID:15064155 PMID:15253041 PMID:18324785 PMID:26602169 PMID:33049310 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Cyp17a1 |
cytochrome P450, family 17, subfamily a, polypeptide 1 |
increases expression |
ISO |
fenarimol results in increased expression of CYP17A1 mRNA; fenarimol results in increased expression of CYP17A1 protein |
CTD |
PMID:21722721 |
|
NCBI chr 1:245,535,462...245,543,148
Ensembl chr 1:245,535,462...245,541,573
|
|
G |
Cyp19a1 |
cytochrome P450, family 19, subfamily a, polypeptide 1 |
decreases activity increases expression |
ISO |
fenarimol results in decreased activity of CYP19A1 protein fenarimol results in increased expression of CYP19A1 mRNA; fenarimol results in increased expression of CYP19A1 protein |
CTD |
PMID:10806373 PMID:11884232 PMID:12127262 PMID:16996190 PMID:21722721 |
|
NCBI chr 8:54,552,978...54,580,375
Ensembl chr 8:54,553,165...54,580,758
|
|
G |
Cyp1a1 |
cytochrome P450, family 1, subfamily a, polypeptide 1 |
multiple interactions |
ISO |
[fenarimol co-treated with acephate] affects the expression of CYP1A1 protein; [fenarimol co-treated with vinclozolin co-treated with acephate] affects the expression of CYP1A1 protein; [fenarimol co-treated with vinclozolin] affects the expression of CYP1A1 protein |
CTD |
PMID:17686559 |
|
NCBI chr 8:58,096,021...58,102,130
Ensembl chr 8:58,096,077...58,102,125
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[fenarimol co-treated with acephate] affects the expression of CYP1A2 protein; [fenarimol co-treated with vinclozolin co-treated with acephate] affects the expression of CYP1A2 protein; [fenarimol co-treated with vinclozolin] affects the expression of CYP1A2 protein |
CTD |
PMID:17686559 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp26a1 |
cytochrome P450, family 26, subfamily a, polypeptide 1 |
increases expression |
EXP |
fenarimol results in increased expression of CYP26A1 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 1:235,471,368...235,475,204
Ensembl chr 1:235,471,298...235,475,204
|
|
G |
Cyp2b3 |
cytochrome P450, family 2, subfamily b, polypeptide 3 |
multiple interactions |
ISO |
[fenarimol co-treated with acephate] affects the expression of CYP2B2 protein; [fenarimol co-treated with vinclozolin co-treated with acephate] affects the expression of CYP2B2 protein; [fenarimol co-treated with vinclozolin] affects the expression of CYP2B2 protein |
CTD |
PMID:17686559 |
|
NCBI chr 1:81,652,762...81,732,153
Ensembl chr 1:81,652,787...81,732,143
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions |
ISO |
[fenarimol co-treated with acephate] affects the expression of CYP2E1 protein; [fenarimol co-treated with vinclozolin co-treated with acephate] affects the expression of CYP2E1 protein; [fenarimol co-treated with vinclozolin] affects the expression of CYP2E1 protein |
CTD |
PMID:17686559 |
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp51 |
cytochrome P450, family 51 |
increases expression |
EXP ISO |
fenarimol results in increased expression of CYP51 mRNA |
CTD |
PMID:28970091 PMID:29337257 |
|
NCBI chr 4:30,036,956...30,055,410
Ensembl chr 4:30,036,865...30,055,410
|
|
G |
Dhcr7 |
7-dehydrocholesterol reductase |
increases expression |
EXP |
fenarimol results in increased expression of DHCR7 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 1:199,015,081...199,031,055
Ensembl chr 1:199,015,081...199,031,055
|
|
G |
Dhrs3 |
dehydrogenase/reductase 3 |
increases expression |
EXP |
fenarimol results in increased expression of DHRS3 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 5:156,747,939...156,782,420
Ensembl chr 5:156,747,962...156,782,417
|
|
G |
Dusp5 |
dual specificity phosphatase 5 |
increases expression |
EXP |
fenarimol results in increased expression of DUSP5 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 1:252,538,408...252,555,320
Ensembl chr 1:252,538,449...252,551,818
|
|
G |
Esr1 |
estrogen receptor 1 |
affects binding increases activity multiple interactions decreases expression |
ISO |
fenarimol binds to ESR1 protein fenarimol results in increased activity of ESR1 protein [Chlorpyrifos co-treated with fenarimol co-treated with Estradiol] results in increased activity of ESR1 protein; afimoxifene inhibits the reaction [[fenarimol co-treated with Estradiol] results in increased activity of ESR1 protein]; afimoxifene inhibits the reaction [fenarimol results in increased activity of ESR1 protein]; fenarimol binds to and results in increased activity of ESR1 protein; fenarimol promotes the reaction [Estradiol results in increased activity of ESR1 protein]; Fulvestrant inhibits the reaction [[fenarimol co-treated with Estradiol] results in increased activity of ESR1 protein]; Fulvestrant inhibits the reaction [fenarimol results in increased activity of ESR1 protein] fenarimol results in decreased expression of ESR1 mRNA |
CTD |
PMID:10789375 PMID:15064155 PMID:15253041 PMID:15261991 PMID:16626760 PMID:20143881 PMID:26812056 PMID:29162470 PMID:33049310 More...
|
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Esr2 |
estrogen receptor 2 |
multiple interactions increases activity increases expression |
ISO |
fenarimol binds to and results in increased activity of ESR2 protein; fenarimol promotes the reaction [Estradiol results in increased expression of ESR2 mRNA] fenarimol results in increased activity of ESR2 protein fenarimol results in increased expression of ESR2 mRNA |
CTD |
PMID:15064155 PMID:15261991 PMID:21722721 PMID:26812056 PMID:33049310 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
G |
Fdft1 |
farnesyl diphosphate farnesyl transferase 1 |
increases expression |
EXP |
fenarimol results in increased expression of FDFT1 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr15:37,412,143...37,440,198
Ensembl chr15:37,412,146...37,440,287
|
|
G |
Fshb |
follicle stimulating hormone subunit beta |
increases expression |
EXP |
fenarimol results in increased expression of FSHB protein |
CTD |
PMID:16324804 |
|
NCBI chr 3:93,548,560...93,552,370
Ensembl chr 3:93,548,560...93,552,370
|
|
G |
Gbx2 |
gastrulation brain homeobox 2 |
increases expression |
EXP |
fenarimol results in increased expression of GBX2 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 9:90,509,633...90,512,212
Ensembl chr 9:90,509,633...90,512,212
|
|
G |
Ggt1 |
gamma-glutamyltransferase 1 |
increases activity |
EXP |
fenarimol results in increased activity of GGT1 protein |
CTD |
PMID:2387028 |
|
NCBI chr20:13,074,695...13,104,095
Ensembl chr20:13,074,700...13,108,442
|
|
G |
Hmgcr |
3-hydroxy-3-methylglutaryl-CoA reductase |
increases expression |
EXP |
fenarimol results in increased expression of HMGCR mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 2:27,997,523...28,018,983
Ensembl chr 2:27,997,525...28,019,703
|
|
G |
Hmgcs1 |
3-hydroxy-3-methylglutaryl-CoA synthase 1 |
increases expression |
EXP |
fenarimol results in increased expression of HMGCS1 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 2:51,649,368...51,667,100
Ensembl chr 2:51,649,497...51,667,100
|
|
G |
Hsd3b1 |
hydroxy-delta-5-steroid dehydrogenase, 3 beta- and steroid delta-isomerase 1 |
increases expression |
ISO |
fenarimol results in increased expression of HSD3B1 mRNA |
CTD |
PMID:21722721 |
|
NCBI chr 2:186,169,864...186,175,984
Ensembl chr 2:186,169,863...186,175,999
|
|
G |
Ifrd1 |
interferon-related developmental regulator 1 |
decreases expression |
EXP |
fenarimol results in decreased expression of IFRD1 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 6:57,269,395...57,317,833
Ensembl chr 6:57,269,384...57,288,990
|
|
G |
Igf1 |
insulin-like growth factor 1 |
decreases expression |
EXP |
fenarimol results in decreased expression of IGF1 mRNA |
CTD |
PMID:15590119 |
|
NCBI chr 7:22,282,895...22,361,972
Ensembl chr 7:22,282,930...22,359,296
|
|
G |
Lhx1 |
LIM homeobox 1 |
increases expression |
EXP |
fenarimol results in increased expression of LHX1 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr10:69,396,829...69,403,617
Ensembl chr10:69,396,829...69,403,617
|
|
G |
Lrrc75a |
leucine rich repeat containing 75A |
increases expression |
EXP |
fenarimol results in increased expression of LRRC75A mRNA |
CTD |
PMID:28970091 |
|
NCBI chr10:47,298,222...47,343,301
Ensembl chr10:47,297,288...47,343,664
|
|
G |
Ltf |
lactotransferrin |
decreases expression |
EXP |
fenarimol results in decreased expression of LTF mRNA |
CTD |
PMID:16324804 |
|
NCBI chr 8:110,999,948...111,022,795
Ensembl chr 8:110,999,948...111,022,795
|
|
G |
Msmo1 |
methylsterol monooxygenase 1 |
increases expression |
EXP |
fenarimol results in increased expression of MSMO1 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr16:24,980,680...24,997,927
Ensembl chr16:24,980,697...24,998,016
|
|
G |
Ngfr |
nerve growth factor receptor |
increases expression |
EXP |
fenarimol results in increased expression of NGFR mRNA |
CTD |
PMID:28970091 |
|
NCBI chr10:80,515,287...80,533,518
Ensembl chr10:80,515,299...80,533,518
|
|
G |
Nobox |
NOBOX oogenesis homeobox |
increases expression |
ISO |
fenarimol results in increased expression of NOBOX mRNA; fenarimol results in increased expression of NOBOX protein |
CTD |
PMID:21722721 |
|
NCBI chr 4:72,128,931...72,134,436
Ensembl chr 4:72,128,931...72,134,436
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
increases activity multiple interactions |
ISO |
fenarimol results in increased activity of NR1I2 protein fenarimol binds to and results in increased activity of NR1I2 protein |
CTD |
PMID:16565514 PMID:21115097 PMID:33049310 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nsdhl |
NAD(P) dependent steroid dehydrogenase-like |
increases expression |
EXP |
fenarimol results in increased expression of NSDHL mRNA |
CTD |
PMID:28970091 |
|
NCBI chr X:150,775,034...150,807,161
Ensembl chr X:150,775,080...150,807,142
|
|
G |
Odc1 |
ornithine decarboxylase 1 |
decreases expression |
EXP |
fenarimol results in decreased expression of ODC1 mRNA |
CTD |
PMID:15590119 |
|
NCBI chr 6:40,329,831...40,336,444
Ensembl chr 6:40,329,964...40,336,440
|
|
G |
Pparg |
peroxisome proliferator-activated receptor gamma |
multiple interactions |
ISO |
fenarimol binds to and results in increased activity of PPARG protein |
CTD |
PMID:33049310 |
|
NCBI chr 4:148,423,102...148,548,471
Ensembl chr 4:148,423,194...148,548,468
|
|
G |
Rarb |
retinoic acid receptor, beta |
increases expression |
EXP |
fenarimol results in increased expression of RARB mRNA |
CTD |
PMID:28970091 |
|
NCBI chr15:8,700,533...9,051,288
Ensembl chr15:8,406,492...9,051,288
|
|
G |
Rasd1 |
ras related dexamethasone induced 1 |
increases expression |
EXP |
fenarimol results in increased expression of RASD1 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr10:44,766,451...44,775,773
Ensembl chr10:44,766,455...44,768,186
|
|
G |
Rflna |
refilin A |
increases expression |
EXP |
fenarimol results in increased expression of RFLNA mRNA |
CTD |
PMID:28970091 |
|
NCBI chr12:31,633,360...31,642,313
Ensembl chr12:31,633,361...31,642,317
|
|
G |
Sc5d |
sterol-C5-desaturase |
increases expression |
EXP |
fenarimol results in increased expression of SC5D mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 8:42,629,649...42,641,257
Ensembl chr 8:42,632,672...42,641,273
|
|
G |
Scd |
stearoyl-CoA desaturase |
increases expression |
EXP |
fenarimol results in increased expression of SCD1 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 1:243,269,745...243,282,878
Ensembl chr 1:243,269,747...243,282,562
|
|
G |
Scube1 |
signal peptide, CUB domain and EGF like domain containing 1 |
increases expression |
EXP |
fenarimol results in increased expression of SCUBE1 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 7:114,759,016...114,880,995
Ensembl chr 7:114,759,010...114,880,940
|
|
G |
Srd5a2 |
steroid 5 alpha-reductase 2 |
decreases activity |
ISO |
fenarimol results in decreased activity of SRD5A2 protein |
CTD |
PMID:17218080 |
|
NCBI chr 6:21,426,225...21,465,727
Ensembl chr 6:21,426,215...21,462,112
|
|
G |
Srebf2 |
sterol regulatory element binding transcription factor 2 |
increases expression |
EXP |
fenarimol results in increased expression of SREBF2 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 7:113,663,202...113,720,850
Ensembl chr 7:113,663,202...113,720,848
|
|
G |
St3gal3 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 3 |
increases expression |
EXP |
fenarimol results in increased expression of ST3GAL3 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 5:131,470,348...131,670,794
Ensembl chr 5:131,470,348...131,670,810
|
|
G |
Stambpl1 |
STAM binding protein-like 1 |
increases expression |
EXP |
fenarimol results in increased expression of STAMBPL1 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr 1:231,699,620...231,745,034
Ensembl chr 1:231,699,995...231,745,032
|
|
G |
Thra |
thyroid hormone receptor alpha |
multiple interactions |
ISO |
fenarimol binds to and results in decreased activity of THRA protein |
CTD |
PMID:33049310 |
|
NCBI chr10:83,701,885...83,729,408
Ensembl chr10:83,700,755...83,729,936
|
|
G |
Thrb |
thyroid hormone receptor beta |
multiple interactions |
ISO |
fenarimol binds to and results in decreased activity of THRB protein |
CTD |
PMID:33049310 |
|
NCBI chr15:7,685,180...8,031,920
Ensembl chr15:7,685,180...7,882,916
|
|
G |
Trdmt1 |
tRNA aspartic acid methyltransferase 1 |
decreases expression |
EXP |
fenarimol results in decreased expression of TRDMT1 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr17:76,601,966...76,646,104
Ensembl chr17:76,610,543...76,645,439
|
|
G |
Zfp496 |
zinc finger protein 496 |
increases expression |
EXP |
fenarimol results in increased expression of ZFP496 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr10:44,268,923...44,287,795
Ensembl chr10:44,268,928...44,287,651
|
|
G |
Zfp703 |
zinc finger protein 703 |
increases expression |
EXP |
fenarimol results in increased expression of ZFP703 mRNA |
CTD |
PMID:28970091 |
|
NCBI chr16:65,076,507...65,080,677
Ensembl chr16:65,076,507...65,080,677
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
mepanipyrim binds to and results in increased activity of AHR protein |
CTD |
PMID:23436777 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of AIF1 protein [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of AIF1 protein] |
CTD |
PMID:31939705 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
App |
amyloid beta precursor protein |
multiple interactions |
ISO |
[APP gene mutant form results in increased expression of APP protein modified form] which results in increased susceptibility to mepanipyrim; [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of AIF1 protein]; [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of GFAP protein]; [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of IL1B protein]; [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of IL6 protein]; APP protein modified form results in increased susceptibility to [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] |
CTD |
PMID:31939705 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Bace1 |
beta-secretase 1 |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of BACE1 protein |
CTD |
PMID:31939705 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
|
|
G |
Esr1 |
estrogen receptor 1 |
increases activity |
EXP |
mepanipyrim results in increased activity of ESR1 protein |
CTD |
PMID:33352482 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of GFAP protein] [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of GFAP protein |
CTD |
PMID:31939705 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of IL1B protein] |
CTD |
PMID:31939705 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of IL6 protein] |
CTD |
PMID:31939705 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
increases expression |
ISO |
mepanipyrim results in increased expression of NRF1 mRNA |
CTD |
PMID:33352482 |
|
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
|
|
|
G |
Adipoq |
adiponectin, C1Q and collagen domain containing |
affects binding |
ISO |
nuarimol binds to ADIPOQ protein |
CTD |
PMID:32278787 |
|
NCBI chr11:77,721,912...77,735,644
Ensembl chr11:77,721,912...77,735,564
|
|
G |
Esr2 |
estrogen receptor 2 |
affects binding |
ISO |
nuarimol binds to ESR2 protein |
CTD |
PMID:32278787 |
|
NCBI chr 6:94,858,438...94,909,630
Ensembl chr 6:94,809,547...94,908,919
|
|
|
G |
Ahr |
aryl hydrocarbon receptor |
multiple interactions |
ISO |
pyrimethanil binds to and results in increased activity of AHR protein |
CTD |
PMID:23436777 |
|
NCBI chr 6:52,234,089...52,271,568
Ensembl chr 6:52,234,089...52,271,568
|
|
G |
Aif1 |
allograft inflammatory factor 1 |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of AIF1 protein] [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of AIF1 protein |
CTD |
PMID:31939705 |
|
NCBI chr20:3,646,784...3,652,670
Ensembl chr20:3,646,777...3,652,668
|
|
G |
App |
amyloid beta precursor protein |
affects binding multiple interactions |
ISO |
pyrimethanil binds to APP protein modified form [APP gene mutant form results in increased expression of APP protein modified form] which results in increased susceptibility to pyrimethanil; [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of AIF1 protein]; [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of GFAP protein]; [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of IL1B protein]; [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of IL6 protein]; APP protein modified form results in increased susceptibility to [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] |
CTD |
PMID:31939705 |
|
NCBI chr11:24,019,774...24,236,584
Ensembl chr11:24,019,778...24,236,561
|
|
G |
Ar |
androgen receptor |
increases expression multiple interactions |
ISO |
pyrimethanil results in increased expression of AR mRNA pyrimethanil inhibits the reaction [Dihydrotestosterone results in increased expression of AR mRNA] |
CTD |
PMID:21310686 |
|
NCBI chr X:63,104,771...63,273,934
Ensembl chr X:63,104,771...63,273,925
|
|
G |
Bace1 |
beta-secretase 1 |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of BACE1 protein |
CTD |
PMID:31939705 |
|
NCBI chr 8:46,142,060...46,166,268
Ensembl chr 8:46,142,116...46,165,876
|
|
G |
Casp3 |
caspase 3 |
multiple interactions affects expression |
ISO |
[pyrimethanil co-treated with cyprodinil co-treated with fludioxonil] results in increased expression of CASP3 mRNA pyrimethanil affects the expression of CASP3 mRNA |
CTD |
PMID:22880100 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
multiple interactions |
ISO |
[N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide co-treated with pyrimethanil co-treated with Fenitrothion co-treated with triadimefon co-treated with quinoxyfen co-treated with penconazole] results in increased expression of CYP3A4 mRNA |
CTD |
PMID:25028461 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Esr1 |
estrogen receptor 1 |
increases activity |
EXP |
pyrimethanil results in increased activity of ESR1 protein |
CTD |
PMID:33352482 |
|
NCBI chr 1:41,106,335...41,499,104
Ensembl chr 1:41,210,475...41,495,002
|
|
G |
Gfap |
glial fibrillary acidic protein |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of GFAP protein] [cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] results in increased expression of GFAP protein |
CTD |
PMID:31939705 |
|
NCBI chr10:87,852,891...87,861,631
Ensembl chr10:87,852,890...87,861,589
|
|
G |
Gpx1 |
glutathione peroxidase 1 |
affects expression multiple interactions |
ISO |
pyrimethanil affects the expression of GPX1 mRNA [pyrimethanil co-treated with cyprodinil co-treated with fludioxonil] results in increased expression of GPX1 mRNA |
CTD |
PMID:22880100 |
|
NCBI chr 8:109,026,905...109,028,031
Ensembl chr 8:109,026,905...109,028,024
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of IL1B protein] |
CTD |
PMID:31939705 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il6 |
interleukin 6 |
multiple interactions |
ISO |
[cyprodinil co-treated with mepanipyrim co-treated with pyrimethanil] promotes the reaction [[APP gene mutant form results in increased expression of APP protein modified form] which results in increased expression of IL6 protein] |
CTD |
PMID:31939705 |
|
NCBI chr 4:5,214,602...5,219,178
Ensembl chr 4:5,213,394...5,219,178
|
|
G |
Nr1i2 |
nuclear receptor subfamily 1, group I, member 2 |
multiple interactions |
ISO |
[N-(2,3-dichloro-4-hydroxyphenyl)-1-methylcyclohexanecarboxamide co-treated with pyrimethanil co-treated with Fenitrothion co-treated with triadimefon co-treated with quinoxyfen co-treated with penconazole] results in increased activity of NR1I2 protein |
CTD |
PMID:25028461 |
|
NCBI chr11:62,460,213...62,496,665
Ensembl chr11:62,460,213...62,496,658
|
|
G |
Nrf1 |
nuclear respiratory factor 1 |
increases expression |
ISO |
pyrimethanil results in increased expression of NRF1 mRNA |
CTD |
PMID:33352482 |
|
NCBI chr 4:58,664,932...58,772,328
Ensembl chr 4:58,664,957...58,825,328
|
|
G |
Ptgs2 |
prostaglandin-endoperoxide synthase 2 |
multiple interactions |
ISO |
[pyrimethanil binds to and results in decreased activity of PTGS2 protein] which results in decreased chemical synthesis of and results in decreased secretion of Prostaglandin D2 |
CTD |
PMID:26359731 |
|
NCBI chr13:62,163,936...62,172,193
Ensembl chr13:62,163,932...62,172,188
|
|
G |
Tff1 |
trefoil factor 1 |
increases expression |
ISO |
pyrimethanil results in increased expression of TFF1 mRNA |
CTD |
PMID:33352482 |
|
NCBI chr20:9,235,736...9,239,597
Ensembl chr20:9,235,736...9,239,597
|
|